Advertisement

ADVERTISEMENT

Systemic Sclerosis Podcasts

Podcast

Interstitial Lung Disease and Esophageal Disorders: When Specialties Work Together

01/23/2024

In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...

In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...

In this special podcast Dr Rita...

01/23/2024

Rheumatology & Arthritis

Elizabeth Volkmann

Podcast

Elizabeth Volkmann, MD, on COVID-19 Among Patients With Scleroderma

08/18/2022

In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.

In this podcast, Dr Elizabeth Volkmann from UCLA discusses her experience working with patients who have scleroderma and interstitial lung disease during the pandemic, including the impact of some drugs on vaccine response.

In this podcast, Dr Elizabeth...

08/18/2022

Rheumatology & Arthritis

Podcasts

Kristin Highland, MD, on Diagnosis and Management of Systemic Sclerosis

07/30/2021

Dr Highland, from the Cleveland Clinic, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex disease.

Dr Highland, from the Cleveland Clinic, provides an overview of systemic sclerosis and associated interstitial lung disease, including symptoms and diagnosis, who's at risk, and new and upcoming treatments for this complex disease.

Dr Highland, from the Cleveland...

07/30/2021

Rheumatology & Arthritis

Advertisement

Podcast

Elizabeth Volkmann, MD, on Treating and Monitoring Patients With SSc-ILD

07/21/2021

In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients...

In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients...

In this podcast, Dr Volkmann,...

07/21/2021

Rheumatology & Arthritis

Podcasts

Elizabeth Volkmann, MD, on the Gut Microbiome in Systemic Sclerosis

05/13/2021

In this podcast, Elizabeth Volkmann, MD, discusses her research into how the gut microbiome of patients with systemic sclerosis may be associated with the pathogenesis of the disease, how environmental influences may affect gut dysbiosis, and...

In this podcast, Elizabeth Volkmann, MD, discusses her research into how the gut microbiome of patients with systemic sclerosis may be associated with the pathogenesis of the disease, how environmental influences may affect gut dysbiosis, and...

In this podcast, Elizabeth...

05/13/2021

Rheumatology & Arthritis

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

SPONSORED

Axial Involvement in SpA, Chapter 1

04/26/2022

Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.

Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.

Ethan Craig, MD, MPH, discusses...

04/26/2022

Rheumatology & Arthritis

Advertisement

Popular Articles

FDA Issues Boxed Warning For Gout Treatment

02/25/2019

02/25/2019

Rheumatology & Arthritis

MBDA Score Is Advantageous in Management of Rheumatoid Arthritis

11/26/2018

A high multibiomarker disease activity (MBDA) score demonstrates when a patient with rheumatoid arthritis will most likely add or switch their biologic or Janus Kinase (JAK) inhibitor therapy, according to study...

A high multibiomarker disease activity (MBDA) score demonstrates when a patient with rheumatoid arthritis will most likely add or switch their biologic or Janus Kinase (JAK) inhibitor therapy, according to study...

A high...

11/26/2018

Rheumatology & Arthritis

Poll

Take Our Poll on Subchondroplasty

09/25/2018

What part of the body was subchondroplasty first developed for?HipArmKnee

What part of the body was subchondroplasty first developed for?HipArmKnee

What...

09/25/2018

Rheumatology & Arthritis

GI Issues Cause Osteoporosis Therapy Non-Adherence

11/17/2017

Women with osteoporosis who experience gastrointestinal (GI) events due to osteoporosis medication are less likely to adhere to their therapy regimen, according to a recent study. In the Medication Use Patterns,...

Women with osteoporosis who experience gastrointestinal (GI) events due to osteoporosis medication are less likely to adhere to their therapy regimen, according to a recent study. In the Medication Use Patterns,...

Women...

11/17/2017

Rheumatology & Arthritis

Alendronate Could Reduce Hip Fracture Risk in Patients Taking Glucocorticoids

07/12/2017

Alendronate was found to reduce the risk of hip fracture among older patients taking medium to high doses of prednisolone, according to the findings of a new study. In the retrospective cohort study, the researchers...

Alendronate was found to reduce the risk of hip fracture among older patients taking medium to high doses of prednisolone, according to the findings of a new study. In the retrospective cohort study, the researchers...

...

07/12/2017

Rheumatology & Arthritis

Advertisement

Advertisement